Literature DB >> 16783492

ABC drug transporter at the blood-brain barrier: effects on drug metabolism and drug response.

Martin Ebinger1, Manfred Uhr.   

Abstract

At the blood-brain barrier (BBB) many cellular and dynamic mechanisms influence the cerebral drug metabolism and the drug response. In this review, we focus mainly on the role P-glycoprotein (P-gp) plays at the BBB. This protein is a 170-kDa ATP-dependent drug transport protein, located in the apical membrane of endothelial cells. Utilizing ATP hydrolysis as an energy source, it exports molecules which attempt to pass through the cell membrane from the outside to the inside, protecting cells from toxins and a wide range of substances. We briefly summarize some of the currently available in vivo and in vitro methods to investigate P-gp and its substrates. Hitherto, no chemical characteristic has been discovered that clearly distinguishes substrates from non-substrates of P-gp. We discuss some examples of substrates stressing the diversity of drugs and endogenous substances that relate to P-gp either as a substrate, an inhibitor, an inducer or as a combination of the above. Finally, we discuss genetic polymorphisms of the genes encoding for P-gp and their effects on drug response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783492     DOI: 10.1007/s00406-006-0664-4

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  62 in total

Review 1.  Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.

Authors:  G Lee; S Dallas; M Hong; R Bendayan
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 25.468

Review 2.  Functional expression and localization of P-glycoprotein at the blood brain barrier.

Authors:  Reina Bendayan; Gloria Lee; Moise Bendayan
Journal:  Microsc Res Tech       Date:  2002-06-01       Impact factor: 2.769

Review 3.  Confocal imaging of xenobiotic transport across the blood-brain barrier.

Authors:  David S Miller
Journal:  J Exp Zool A Comp Exp Biol       Date:  2003-11-01

4.  Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  J Histochem Cytochem       Date:  1989-02       Impact factor: 2.479

5.  P-glycoprotein is a factor in the uptake of dextromethorphan, but not of melperone, into the mouse brain: evidence for an overlap in substrate specificity between P-gp and CYP2D6.

Authors:  Manfred Uhr; Christian Namendorf; Markus T Grauer; Markus Rosenhagen; Martin Ebinger
Journal:  J Psychopharmacol       Date:  2004-12       Impact factor: 4.153

6.  Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-beta-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers.

Authors:  Hidetoshi Arima; Kiyokazu Yunomae; Tadatoshi Morikawa; Fumitoshi Hirayama; Kaneto Uekama
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

Review 7.  Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy.

Authors:  Matteo Marroni; Nicola Marchi; Luca Cucullo; N Joan Abbott; Kathy Signorelli; Damir Janigro
Journal:  Curr Drug Targets       Date:  2003-05       Impact factor: 3.465

8.  Expression of the mdr (P-glycoprotein) gene in Chinese hamster digestive tracts.

Authors:  T Mukhopadhyay; J G Batsakis; M T Kuo
Journal:  J Natl Cancer Inst       Date:  1988-04-20       Impact factor: 13.506

Review 9.  Emerging significance of P-glycoprotein in understanding drug disposition and drug interactions in psychopharmacology.

Authors:  Stanley W Carson; Aliou D Ousmanou; Sheri L Hoyler
Journal:  Psychopharmacol Bull       Date:  2002

10.  Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma.

Authors:  Peter Hau; Klaus Fabel; Ulrike Baumgart; Petra Rümmele; Oliver Grauer; Annekatrin Bock; Christopher Dietmaier; Wolfgang Dietmaier; Jörg Dietrich; Christine Dudel; Franz Hübner; Tanya Jauch; Elisabeth Drechsel; Ingo Kleiter; Cäcile Wismeth; Anton Zellner; Alexander Brawanski; Andreas Steinbrecher; Jörg Marienhagen; Ulrich Bogdahn
Journal:  Cancer       Date:  2004-03-15       Impact factor: 6.860

View more
  5 in total

1.  Screening candidate anticancer drugs for brain tumor chemotherapy: pharmacokinetic-driven approach for a series of (E)-N-(substituted aryl)-3-(substituted phenyl)propenamide analogues.

Authors:  Hua Lv; Fan Wang; M V Ramana Reddy; Qingyu Zhou; Xiaoping Zhang; E Premkumar Reddy; James M Gallo
Journal:  Invest New Drugs       Date:  2012-03-01       Impact factor: 3.850

Review 2.  Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings.

Authors:  Fionn E O'Brien; Timothy G Dinan; Brendan T Griffin; John F Cryan
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

3.  Suppression of carboxylesterases by imatinib mediated by the down-regulation of pregnane X receptor.

Authors:  Wenjing Luo; Yu Xin; Xia Zhao; Feng Zhang; Changqing Liu; Hongwei Fan; Tao Xi; Jing Xiong
Journal:  Br J Pharmacol       Date:  2017-03-03       Impact factor: 8.739

4.  Effect of the novel antipsychotic drug perospirone on P-glycoprotein function and expression in Caco-2 cells.

Authors:  Yan-Gang Zhou; Kun-Yan Li; Huan-De Li
Journal:  Eur J Clin Pharmacol       Date:  2008-05-14       Impact factor: 2.953

Review 5.  The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy.

Authors:  Zefeng Chen; Jingsheng Ruan; Dinghua Li; Min Wang; Zhiwei Han; Wenxia Qiu; Guobin Wu
Journal:  Front Cell Infect Microbiol       Date:  2021-01-21       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.